CA2655723C - Compositions and methods of making a photoactive agent - Google Patents

Compositions and methods of making a photoactive agent Download PDF

Info

Publication number
CA2655723C
CA2655723C CA2655723A CA2655723A CA2655723C CA 2655723 C CA2655723 C CA 2655723C CA 2655723 A CA2655723 A CA 2655723A CA 2655723 A CA2655723 A CA 2655723A CA 2655723 C CA2655723 C CA 2655723C
Authority
CA
Canada
Prior art keywords
chlorin
salt
formula
combining
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2655723A
Other languages
English (en)
French (fr)
Other versions
CA2655723A1 (en
Inventor
Leon Xu
Alexander J. Pallenberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Light Sciences Oncology Inc
Original Assignee
Euro Celtique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique SA filed Critical Euro Celtique SA
Publication of CA2655723A1 publication Critical patent/CA2655723A1/en
Application granted granted Critical
Publication of CA2655723C publication Critical patent/CA2655723C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2655723A 2006-06-30 2007-06-29 Compositions and methods of making a photoactive agent Active CA2655723C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81776906P 2006-06-30 2006-06-30
US60/817,769 2006-06-30
PCT/US2007/015087 WO2008005308A2 (en) 2006-06-30 2007-06-29 Compositions and methods of making a chlorin e6 derivative as a photoactive agent

Publications (2)

Publication Number Publication Date
CA2655723A1 CA2655723A1 (en) 2008-01-10
CA2655723C true CA2655723C (en) 2014-11-18

Family

ID=38739490

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2655723A Active CA2655723C (en) 2006-06-30 2007-06-29 Compositions and methods of making a photoactive agent

Country Status (10)

Country Link
US (3) US8198312B2 (https=)
EP (1) EP2057169A2 (https=)
JP (1) JP5323693B2 (https=)
KR (1) KR101456839B1 (https=)
CN (1) CN101490057B (https=)
AU (1) AU2007269784B2 (https=)
CA (1) CA2655723C (https=)
RU (1) RU2009102973A (https=)
SG (1) SG172733A1 (https=)
WO (1) WO2008005308A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2885311Y (zh) 2006-01-18 2007-04-04 郑成福 经尿道光动力疗法前列腺治疗仪
WO2007130465A2 (en) * 2006-05-02 2007-11-15 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
US7465312B2 (en) 2006-05-02 2008-12-16 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
JP5323693B2 (ja) 2006-06-30 2013-10-23 ライト、サイエンシーズ、オンコロジー、インコーポレイテッド 光活性剤としてのクロリンｅ６誘導体の組成物およびクロリンｅ６誘導体を製造する方法
CN103030644B (zh) * 2011-09-30 2015-01-14 齐鲁制药有限公司 一种他拉泊芬及其中间体的制备方法
US10276260B2 (en) 2012-08-16 2019-04-30 Ginger.io, Inc. Method for providing therapy to an individual
US10748645B2 (en) 2012-08-16 2020-08-18 Ginger.io, Inc. Method for providing patient indications to an entity
US10650920B2 (en) 2012-08-16 2020-05-12 Ginger.io, Inc. Method and system for improving care determination
US10741285B2 (en) 2012-08-16 2020-08-11 Ginger.io, Inc. Method and system for providing automated conversations
US9836581B2 (en) 2012-08-16 2017-12-05 Ginger.io, Inc. Method for modeling behavior and health changes
US10740438B2 (en) 2012-08-16 2020-08-11 Ginger.io, Inc. Method and system for characterizing and/or treating poor sleep behavior
RU2523380C1 (ru) * 2013-05-21 2014-07-20 Общество с ограниченной ответственностью "ГЕЛИОХЛОРИН" Фотосенсибилизатор и способ его получения
KR20260014087A (ko) 2024-07-22 2026-01-30 최병균 중력을 이용한 순환 수력 발전시스템

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693885A (en) 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4656186A (en) 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4977177A (en) * 1985-04-30 1990-12-11 Nippon Petrochemicals Company, Ltd. Tetrapyrrole polyaminomonocarboxylic acid therapeutic agents
JP3565442B2 (ja) 1993-04-22 2004-09-15 新日本石油化学株式会社 哺乳類の関節炎の診断剤および／または治療剤
JP5323693B2 (ja) 2006-06-30 2013-10-23 ライト、サイエンシーズ、オンコロジー、インコーポレイテッド 光活性剤としてのクロリンｅ６誘導体の組成物およびクロリンｅ６誘導体を製造する方法

Also Published As

Publication number Publication date
US20110105745A1 (en) 2011-05-05
CA2655723A1 (en) 2008-01-10
WO2008005308A3 (en) 2008-03-06
RU2009102973A (ru) 2010-08-10
US20080021210A1 (en) 2008-01-24
EP2057169A2 (en) 2009-05-13
KR101456839B1 (ko) 2014-11-03
US8198312B2 (en) 2012-06-12
CN101490057B (zh) 2013-02-27
CN101490057A (zh) 2009-07-22
WO2008005308A2 (en) 2008-01-10
US8822677B2 (en) 2014-09-02
KR20090033463A (ko) 2009-04-03
US20130281689A1 (en) 2013-10-24
AU2007269784B2 (en) 2012-07-05
JP5323693B2 (ja) 2013-10-23
JP2009542672A (ja) 2009-12-03
US8063203B2 (en) 2011-11-22
AU2007269784A1 (en) 2008-01-10
SG172733A1 (en) 2011-07-28

Similar Documents

Publication Publication Date Title
CA2655723C (en) Compositions and methods of making a photoactive agent
JP2009542672A5 (https=)
CN110330500B (zh) 一种6β-羟基-7,8-二氢-吗啡衍生物的立体选择性合成方法
US12173011B2 (en) Compounds and methods of their manufacturing
WO2003042215A1 (en) Process for the preparation of crystalline imipenem
CA2243592C (en) Method of production of lovastatin
CN120943886A (zh) 一种三肽Fmoc-Pro-Pro-Pro-OH的合成方法
CN112521392A (zh) 一种二氢卟吩e6的纯化方法
RO111677B1 (ro) Procedeu si intermediar pentru prepararea oxitetraciclinei pure
WO2004106355A1 (en) Addition salts of azithromycin and citric acid and process for preparing them
CN121914125A (zh) 一种脱镁叶绿酸a甲酯的制备方法
KR100502834B1 (ko) 개선된 락톤화 반응에 의한 심바스타틴의 제조방법 및이의 정제방법
KR20110103711A (ko) 신규 결정형의 자나미비어 수화물 및 이의 제조방법
CA3268625A1 (en) Process for the extraction of phragmalin derivatives from entandrophragma caudatum seed and preparation of pharmaceutically active limonoids
CN117965653A (zh) 一种氟雷拉纳关键中间体的酶合成方法
CN118271251A (zh) 一种中间体化合物及其制备方法和制备达普司他的方法
CN115785067A (zh) 一种艾司奥美拉唑硫醚的杂质化合物的制备方法
CN114426482A (zh) 单水合曲前列环素晶体和其制备方法
AU2002347451A1 (en) Process for the preparation of crystalline imipenem
JPH06157541A (ja) 新規なオキサゾピロロキノリン化合物
FR2467853A1 (fr) Procede de production d'ester de 1,3-dihydro-3-oxo-1-isobenzofurannyle d'acide (2s)-6-((amino-phenylacetyl)-amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0.) heptane-2-carboxylique

Legal Events

Date Code Title Description
EEER Examination request
H11 Ip right ceased following rejected request for revival

Free format text: ST27 STATUS EVENT CODE: T-6-6-H10-H11-H101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TIME LIMIT FOR REVERSAL EXPIRED

Effective date: 20241230